Femtogenix develop next generation DNA-interactive payload molecules for use in antibody-drug conjugates with payloads designed through a development platform combining proprietary computational chemistry techniques, and founder know-how gained from a combined 50+ years of experience in DNA-targeted drug discovery and development.
** content-page.php **